EquitiesIndia.com

Healthcare · Drug Manufacturers - Specialty & Generic

Piramal Pharma Ltd.

PPLPHARMA

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; offers inhalation anesthetics, intrathecal therapy, injectable pain and anesthesia drugs, and other generic and specialty products; and analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene, as well as adult incontinence. The company was incorporated in 2020 and is based in Mumbai, India.

NSE: PPLPHARMAOfficial website ↗

Key metrics

Market Cap

₹19,329 cr

P/E Ratio

P/B Ratio

2.38x

ROE

1.12%

ROCE

6.41%

Debt / Equity

0.6x

Net Margin

1.01%

Dividend Yield

10%

EPS

₹0.68

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 54.60%FII: 20.43%Public: 24.97%

Deep-dive pages

Educational content — not investment adviceThis page presents publicly available information about Piramal Pharma Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.